Executive Vice President and General Counsel of RNST sells 6,000 shares in insider transaction

Mark Jeanfreau, who serves as the EVP/General Counsel of $RNST, completed a transaction on 02-02-2026 involving the sale of 6,000 shares of the company. The value of this stock sale amounted to an estimated $227,278, as reported in a recent filing with the SEC. By divesting 6,000 shares, Jeanfreau significantly reduced their stake by approximately 8.4% in this particular class of shares. Following this sale, their ownership now stands at 65,172 shares of the same class of $RNST stock.

Over the past half-year, $RNST insiders have actively engaged in 3 transactions involving the company’s stock on the open market. Out of these transactions, 1 was a purchase while 2 were sales. Notably, James C. IV Mabry, serving as the EVP and CFO, sold 12,500 shares for an estimated $472,932. Furthermore, Jonathan A Levy made a purchase of 2,000 shares for an estimated $69,577, reflecting varied activities within the company’s insider trading sphere.

On the institutional front, a total of 114 institutional investors have opted to increase their stakes in $RNST stock in the latest quarter. On the contrary, 125 institutional investors have chosen to reduce their positions over the same period. Significant movements include Channing Capital Management, LLC acquiring 1,648,550 shares at an estimated value of $60,815,009 in Q3 2025 and Victory Capital Management Inc decreasing their shareholding by 491,589 shares in the same quarter.

In terms of revenue, $RNST recorded revenues worth $278.5M in Q4 2025, marking a substantial 66.68% increase from the previous year’s comparative period. The company’s financial performance can be meticulously tracked on Quiver Quantitative’s dedicated RNST stock page, providing investors with crucial insights into the stock’s financial health.

Meanwhile, Wall Street analysts have been closely monitoring $RNST’s performance in recent months, with 2 firms issuing buy ratings on the stock. Notably, Hovde Group released an “Outperform” rating on 10/30/2026, and TD Cowen issued a “Buy” rating on the same day, indicating a positive sentiment towards $RNST’s outlook.

On the price target front, multiple analysts have assessed $RNST’s valuation and provided the market with their projections. Two analysts have furnished price targets for the company in the past six months, with a median target of $43.0. Noteworthy targets include Janet Lee from TD Cowen setting a target price of $45.0 on 01/07/2026 and David Bishop from Hovde Group establishing a target price of $41.0 on 10/30/2025. These analysts’ projections shed light on their expectations regarding $RNST’s future stock performance.